| Name | Title | Contact Details |
|---|
Caregiver Homes from Seniorlink is an innovative, proven model of full-time in-home care and support for elders and individuals with disabilities that offers families a quality alternative to care that depends on facilities or home health aides. Through financial assistance, as well as dedicated care managers and nurses who provide daily support and monitoring to ensure success for both the consumer and caregiver, Caregiver Homes makes it possible for families to provide around-the-clock care for elders and those with disabilities. We began Caregiver Homes in 2005 because we felt that caring for loved ones at home should be an option that is available to families. And we believed that caregivers should have access to the support they need. In addition to giving families a choice, caregiving at home is more cost effective for Medicaid than nursing facilities. Through a pilot program in Massachusetts, Caregiver Homes tested this new model of care: 24/7 care by a professionally supported, paid live-in caregiver of the consumer`s choosing. The pilot proved that elders needing help with three or more personal care needs-often with multiple chronic conditions—could be cared for at home at half the cost of nursing facility placement. In response to the pilot, Massachusetts made Structured Family Caregiving—known in the Commonwealth as Enhanced Adult Foster Care—a permanent part of its Medicaid program for individuals with complex care needs from all backgrounds. Caregiver Homes took on its first consumer in February 2007. Since 2007, enrollment has grown rapidly as awareness of Caregiver Homes has grown. Caregiver Homes now proudly serves more than 2,300 consumers across Massachusetts, Rhode Island (2010), Ohio (2012), Indiana (2013), and Connecticut (2014).
With over 40 years in business, Coast Medical Service is LA’s premier nurse staffing agency serving hospitals, per diem nurses and travel nurses. Learn more.
Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome. The HBV program is focused on advancing a new class of potent, oral core inhibitors that have the potential to increase cure rates for chronically infected patients. The microbiome program is developing novel oral live microbial biotherapeutic candidates with Assembly`s fully integrated platform, including a robust process for strain identification and selection, GMP banking and production, and targeted delivery to the lower gastrointestinal tract with the GEMICEL® technology. We pride ourselves on creating a culture and work environment that is scientifically driven, ambitious, and collaborative. We encourage diversity of thought that leads to great innovation and are looking to add to our dynamic team great people who are driven to transform the lives of patients. We believe our Microbiome platform represents a best in class approach to developing biopharmaceutical agents from live biotherapeutic products. ABI-M201, our lead program in mildly to moderately active ulcerative colitis (UC), is currently in a phase 1b clinical trial. This program is part of a broader collaboration we established with Allergan in 2017 for gastrointestinal programs such as UC, Crohn`s disease and Irritable Bowel Syndromes with potential total development and commercial milestones of up to $2.8 billion. Our internal pipeline comprises first in class or best in class live microbial biotherapeutic approaches in areas such as oncology, immune mediated and metabolic disorders, and other areas of high medical need. Assembly is headquartered in Carmel, Indiana, while the R&D headquarters is in South San Francisco. The Company also has a microbiome manufacturing facility in Groton, CT, and offices in China.
Lively provides hearing devices from the convenience of your home, all under the guidance of a doctor for 50% less than the national average.